<H1>Chapter DOI: 10.1208/aapsj070373<br/>Cited-By Count: 54</H1><table border="1" width="30%"><tr><td>Total References</td><td>122</td></tr><tr><td>Springer references</td><td>1</td></tr><tr><td>Non Springer references</td><td>121</td></tr><tr><td>BibStructured Count</td><td width="10%">122</td></tr><tr><td>BibUnstructured Count</td><td width="10%">0</td></tr><tr><td>DOI already available in SpringerLink</td><td>89</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>8</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>8</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>8</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr><tr><td>Valid DOI Enriched</td><td>5</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Heinz A, Mann K, Weinberger DR, Goldman D. Serotonergic dysfunction, negative mood states, and response to alcohol.<Emphasis Type="Italic">Alcohol Clin Exp Res.</Emphasis> 2001;25:487&#8211;495.</td><td><a href=http://dx.doi.org/10.1111/j.1530-0277.2001.tb02240.x>10.1111/j.1530-0277.2001.tb02240.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Hahn MK, Blakely RD. Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders.<Emphasis Type="Italic">Pharmacogenomics J.</Emphasis> 2002;2:217&#8211;235.</td><td><a href=http://dx.doi.org/10.1038/sj.tpj.6500106>10.1038/sj.tpj.6500106</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Rocha BA, Fumagalli F, Gainetdinov RR, et al. Cocaine self-administration in dopamine-transporter knockout mice.<Emphasis Type="Italic">Nat Neurosci.</Emphasis> 1998;1:132&#8211;137.</td><td><a href=http://dx.doi.org/10.1038/1152>10.1038/1152</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Sora I, Hall FS, Andrews AM, et al. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2001;98:5300&#8211;5305.</td><td><a href=http://dx.doi.org/10.1073/pnas.091039298>10.1073/pnas.091039298</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Flattem NL, Blakely RD. Modified structure of the human serotonin transporter promoter.<Emphasis Type="Italic">Mol Psychiatry</Emphasis> 2000;5:110&#8211;115.</td><td><a href=http://dx.doi.org/10.1038/sj.mp.4000585>10.1038/sj.mp.4000585</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>McCauley JL, Olson LM, Dowd M, et al. Linkage and association analysis at the serotonin transporter (SLC6A4) locus in a rigid-compulsive subset of autism.<Emphasis Type="Italic">Am J Med Genet B Neuropsychiatr Genet.</Emphasis> 2004;127:104&#8211;112.</td><td><a href=http://dx.doi.org/10.1002/ajmg.b.20151>10.1002/ajmg.b.20151</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Ozaki N, Goldman D, Kaye WH, et al. Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype.<Emphasis Type="Italic">Mol Psychiatry</Emphasis> 2003;8:895&#8211;936.</td><td><a href=http://dx.doi.org/10.1038/sj.mp.4001415>10.1038/sj.mp.4001415</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Kilic F, Murphy DL, Rudnick G. A human serotonin transporter mutation causes constitutive activation of transport activity.<Emphasis Type="Italic">Mol Pharmacol.</Emphasis> 2003;64:440&#8211;446.</td><td><a href=http://dx.doi.org/10.1124/mol.64.2.440>10.1124/mol.64.2.440</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Astier B, Van Bockstaele EJ, Aston-Jones G, Pieribone VA. Anatomical evidence for multiple pathways leading from the rostral ventrolateral medulla (nucleus paragigantocellularis) to the locus coeruleus in rat.<Emphasis Type="Italic">Neurosci Lett.</Emphasis> 1990;118:141&#8211;146.</td><td><a href=http://dx.doi.org/10.1016/0304-3940(90)90612-D>10.1016/0304-3940(90)90612-D</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Pavcovich LA, Cancela LM, Volosin M, Molina VA, Ramirez OA. Chronic stress-induced changes in locus coeruleus neuronal activity.<Emphasis Type="Italic">Brain Res Bull.</Emphasis> 1990;24:293&#8211;296.</td><td><a href=http://dx.doi.org/10.1016/0361-9230(90)90219-P>10.1016/0361-9230(90)90219-P</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Holden JE, Naleway E. Microinjection of carbachol in the lateral hypothalamus produces opposing actions on nociception mediated by alpha(1)- and alpha(2)-adrenoceptors.<Emphasis Type="Italic">Brain Res.</Emphasis> 2001;911:27&#8211;36.</td><td><a href=http://dx.doi.org/10.1016/S0006-8993(01)02567-7>10.1016/S0006-8993(01)02567-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Jasmin L, Tien D, Weinshenker D. The NK1 receptor mediates both the hyperalgesia and the resistance to morphine in mice lacking noradrenaline.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2002;99:1029&#8211;1034.</td><td><a href=http://dx.doi.org/10.1073/pnas.012598599>10.1073/pnas.012598599</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Axelrod J, Kopin IJ. The uptake, storage, release, and metabolism of noradrenaline in sympathetice nerves.<Emphasis Type="Italic">Prog Brain Res.</Emphasis> 1969;31:21&#8211;32.</td><td><a href=http://dx.doi.org/10.1016/S0079-6123(08)63224-0>10.1016/S0079-6123(08)63224-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibChapter</td><td>Iversen LL. Uptake processes for biogenic amines. In: Iversen I, ed.<Emphasis Type="Italic">Handbook of Psychopharmacology</Emphasis>. 3rd ed. New York, NY: Prenum Press; 1978;381&#8211;442.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1007/978-1-4684-3189-6>10.1007/978-1-4684-3189-6</a></td><td><b>CrossRef-Meta</b></td>
<td>BookTitle, Year</td><td>CrossRef</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Pacholczyk T, Blakely RD, Amara SG. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter.<Emphasis Type="Italic">Nature</Emphasis>. 1991;350:350&#8211;354.</td><td><a href=http://dx.doi.org/10.1038/350350a0>10.1038/350350a0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Amara SG, Arriza JL. Neurotransmitter transporters: three distinct gene families.<Emphasis Type="Italic">Curr Opin Neurobiol.</Emphasis> 1993;3:337&#8211;344.</td><td><a href=http://dx.doi.org/10.1016/0959-4388(93)90126-J>10.1016/0959-4388(93)90126-J</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Klimek V, Stockmeier C, Overholser J, et al. Reduced levels of norepinephrine transporters in the locus coeruleus in major depression.<Emphasis Type="Italic">J Neurosci.</Emphasis> 1997;17:8451&#8211;8458.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Ganguly PK, Dhalla KS, Imes IR, Beamish RE, Dhall NS. Altered norepinephrine turnover and metabolism in diabetic cardiomyopathy.<Emphasis Type="Italic">Circ Res.</Emphasis> 1986;59:684&#8211;693.</td><td><a href=http://dx.doi.org/10.1161/01.RES.59.6.684>10.1161/01.RES.59.6.684</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, Author_FamilyName_2, Year, ArticleTitle, FirstPage, VolumeID</td><td>CrossRef</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Merlet P, Dubois-Rande J-L, Adnot S, et al. Myocardial b-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy.<Emphasis Type="Italic">J Cardiovasc Pharmacol.</Emphasis> 1992;19:10&#8211;16.</td><td><a href=http://dx.doi.org/10.1097/00005344-199201000-00002>10.1097/00005344-199201000-00002</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Robertson D, Flattem N, Tellioglu T, et al., Familial orthostatic tachycardia due to norepinephrine transporter deficiency.<Emphasis Type="Italic">Ann N Y Acad Sci.</Emphasis> 2001;940:527&#8211;543.</td><td><a href=http://dx.doi.org/10.1111/j.1749-6632.2001.tb03703.x>10.1111/j.1749-6632.2001.tb03703.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Xu F, Gainetdinov RR, Wetsel WC, et al. Mice lacking the norepinephrine transporter are supersensitive to psychostimulants.<Emphasis Type="Italic">Nat Neurosci.</Emphasis> 2000;3:465&#8211;471.</td><td><a href=http://dx.doi.org/10.1038/74839>10.1038/74839</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Thompson AC, Zapata A, Justice JB, Vaughan RA, Sharpe LG, Shippenberg TS. Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine.<Emphasis Type="Italic">J Neurosci.</Emphasis> 2000;20:9333&#8211;9340.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Hahn MK, Robertson D, Blakely RD. A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters.<Emphasis Type="Italic">J Neurosci.</Emphasis> 2003;23:4470&#8211;4478.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M, Carlsson ML. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence.<Emphasis Type="Italic">Annu Rev Pharmacol Toxicol.</Emphasis> 2001;41:237&#8211;260.</td><td><a href=http://dx.doi.org/10.1146/annurev.pharmtox.41.1.237>10.1146/annurev.pharmtox.41.1.237</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Greengard P. The neurobiology of slow synaptic transmission.<Emphasis Type="Italic">Science</Emphasis>. 2001;294:1024&#8211;1030.</td><td><a href=http://dx.doi.org/10.1126/science.294.5544.1024>10.1126/science.294.5544.1024</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, Ewing A. Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport.<Emphasis Type="Italic">J Neurosci.</Emphasis> 1995;15:4102&#8211;4108.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Sora I, Wichems C, Takahashi N, et al. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1998;95:7699&#8211;7704.</td><td><a href=http://dx.doi.org/10.1073/pnas.95.13.7699>10.1073/pnas.95.13.7699</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Rioux A, Fabre V, Lesch KP, et al. Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporter.<Emphasis Type="Italic">Neurosci Lett.</Emphasis> 1999;262:113&#8211;116.</td><td><a href=http://dx.doi.org/10.1016/S0304-3940(99)00049-X>10.1016/S0304-3940(99)00049-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Carboni E, Spielewoy C, Vacca C, Nosten-Bertrand M, Giros B, Di Chiara G. Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene.<Emphasis Type="Italic">J Neurosci.</Emphasis> 2001;21:1&#8211;4.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Kula NS, Baldessarini RJ. Lack of increase in dopamine transporter binding or functions in rat brain tissue after treatment with blockers of neuronal uptake of dopamine.<Emphasis Type="Italic">Neuropharmacology</Emphasis>. 1991;30:89&#8211;92.</td><td><a href=http://dx.doi.org/10.1016/0028-3908(91)90047-F>10.1016/0028-3908(91)90047-F</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Giros B, El Mestikawy S, Godinot N, et al. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter.<Emphasis Type="Italic">Mol Pharmacol.</Emphasis> 1992;42:383&#8211;390.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter.<Emphasis Type="Italic">Nature</Emphasis>. 1996;379:606&#8211;612.</td><td><a href=http://dx.doi.org/10.1038/379606a0>10.1038/379606a0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR33</td><td>BibArticle</td><td>Eichelman BS. Neurochemical and psychopharmacologic aspects of aggressive behavior.<Emphasis Type="Italic">Annu Rev Med.</Emphasis> 1990;41:149&#8211;158.</td><td><a href=http://dx.doi.org/10.1146/annurev.me.41.020190.001053>10.1146/annurev.me.41.020190.001053</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, FirstPage, ArticleTitle, Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR34</td><td>BibArticle</td><td>Comings DE. Clinical and molecular genetics of ADHD and Tourette syndrome: two related polygenic disorders.<Emphasis Type="Italic">Ann NY Acad Sci</Emphasis>. 2001;931:50&#8211;83.</td><td><a href=http://dx.doi.org/10.1111/j.1749-6632.2001.tb05773.x>10.1111/j.1749-6632.2001.tb05773.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR35</td><td>BibArticle</td><td>Meyer JH, Goulding VS, Wilson AA, Hussey D, Christensen BK, Houle S. Bupropion occupancy of the dopamine transporter is low during clinical treatment.<Emphasis Type="Italic">Psychopharmacology (Berl)</Emphasis>. 2002;163:102&#8211;105.</td><td><a href=http://dx.doi.org/10.1007/s00213-002-1166-3>10.1007/s00213-002-1166-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR36</td><td>BibArticle</td><td>Miller GM II, De La Garza RD II, Novak MA, Madras BK. Single nucleotide polymorphisms distinguish multiple dopamine transporter alleles in primates: implications for association with attention deficit hyperativity disorder and other neuropsychiatric disorders.<Emphasis Type="Italic">Mol Psychiatry</Emphasis>. 2001;6:50&#8211;58.</td><td><a href=http://dx.doi.org/10.1038/sj.mp.4000809>10.1038/sj.mp.4000809</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR37</td><td>BibArticle</td><td>Lin Z, Uhl GR. Dopamine transporter mutants with cocaine resistance and normal dopamine uptake provide targets for cocaine antagonism.<Emphasis Type="Italic">Mol Pharmacol.</Emphasis> 2002;61:885&#8211;891.</td><td><a href=http://dx.doi.org/10.1124/mol.61.4.885>10.1124/mol.61.4.885</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR38</td><td>BibArticle</td><td>Reith MEA, Meisler BE, Sershen H, Lajtha A, Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior.<Emphasis Type="Italic">Biochem Pharmacol.</Emphasis> 1986;35:1123&#8211;1129.</td><td><a href=http://dx.doi.org/10.1016/0006-2952(86)90148-6>10.1016/0006-2952(86)90148-6</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR39</td><td>BibArticle</td><td>Seiden LS, Sabol KE, Ricaurte GA. Amphetamine: effects on catecholamine systems and behavior.<Emphasis Type="Italic">Annu Rev Pharmacol Toxicol</Emphasis>. 1993;33:639&#8211;677.</td><td><a href=http://dx.doi.org/10.1146/annurev.pa.33.040193.003231>10.1146/annurev.pa.33.040193.003231</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR40</td><td>BibArticle</td><td>Bengel D, Murphy DL, Andrews AM, et al. Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxym etamphetamine (&#8220;ecstasy&#8221;) in serotonin transporter-deficient mice.<Emphasis Type="Italic">Mol Pharmacol.</Emphasis> 1998;53:649&#8211;655.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR41</td><td>BibArticle</td><td>Rocha BA, Scearce-Levie K, Lucas JJ, et al. Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor.<Emphasis Type="Italic">Nature</Emphasis>. 1998;393:175&#8211;178.</td><td><a href=http://dx.doi.org/10.1038/30259>10.1038/30259</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR42</td><td>BibArticle</td><td>Nestler EJ, Aghajanian GK. Molecular and cellular basis of addiction.<Emphasis Type="Italic">Science</Emphasis>. 1997;278:58&#8211;63.</td><td><a href=http://dx.doi.org/10.1126/science.278.5335.58>10.1126/science.278.5335.58</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR43</td><td>BibArticle</td><td>Pierce RC, Kalivas PW. Repeated cocaine modifies the mechanism by which amphetamine releases dopamine.<Emphasis Type="Italic">J Neurosci.</Emphasis> 1997;17:3254&#8211;3261.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR44</td><td>BibArticle</td><td>Cases O, Lebrand C, Giros B et al. Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs.<Emphasis Type="Italic">J Neurosci.</Emphasis> 1998;18:6914&#8211;6927.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR45</td><td>BibArticle</td><td>Pan Y, Gembom E, Peng W, Lesch KP, Mossner R, Simantov R. Plasticity in serotonin uptake in primary neuronal cultures of serotonin transporter knockout mice.<Emphasis Type="Italic">Brain Res Dev Brain Res</Emphasis>. 2001;126:125&#8211;129.</td><td><a href=http://dx.doi.org/10.1016/S0165-3806(00)00145-0>10.1016/S0165-3806(00)00145-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR46</td><td>BibArticle</td><td>Moron JA, Brockington A, Wise RA, Rocha BA, Hope BT. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines.<Emphasis Type="Italic">J Neurosci.</Emphasis> 2002;22:389&#8211;395.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR47</td><td>BibArticle</td><td>Ramamoorthy S, Cool DR, Mahesh VB, et al. Regulation of the human serotonin transporter: cholera toxin-induced stimulation of serotonin uptake in human placental choriocarcinoma cells is accompanied by increased serotonin transporter mRNA levels and serotonin transporter-specific ligand binding.<Emphasis Type="Italic">J Biol Chem.</Emphasis> 1993;268:21626&#8211;21631.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR48</td><td>BibArticle</td><td>Ramamoorthy JD, Ramamoorthy S, Papapetropoulos A, Catravas JD, Leibach FH, Ganapathy V. Cyclic AMP-independent up-regulation of the human serotonin transporter by staurosporine in choriocarcinoma cells.<Emphasis Type="Italic">J Biol Chem.</Emphasis> 1995;270:17189&#8211;17195.</td><td><a href=http://dx.doi.org/10.1074/jbc.270.29.17189>10.1074/jbc.270.29.17189</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR49</td><td>BibArticle</td><td>Ramamoorthy S, Ramamoorthy JD, Prasad P, et al. Regulation of the human serotonin transporter by interleukin-1b.<Emphasis Type="Italic">Biochem Biophys Res Commun.</Emphasis> 1995;216:560&#8211;567.</td><td><a href=http://dx.doi.org/10.1006/bbrc.1995.2659>10.1006/bbrc.1995.2659</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR50</td><td>BibChapter</td><td>Blakely RD, Ramamoorthy S, Qian Y, Schroeter S, Bradley C. Regulation of antidepressant-sensitive serotonin transporters. In: Reith MEA, ed.<Emphasis Type="Italic">Neurotransmitter Transporters: Structure, Function, and Regulation</Emphasis>. Totowa, NJ: Humana Press; 1997:29&#8211;72.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1007/978-1-59259-470-2>10.1007/978-1-59259-470-2</a></td><td><b>CrossRef-Meta</b></td>
<td>Year, ChapterTitle</td><td>CrossRef</td></tr><tr><td>CR51</td><td>BibBook</td><td>Bradley CC.<Emphasis Type="Italic">Structure, Regulation, and Expression of the Human Serotonin Transporter Gene [Doctoral dissertation]</Emphasis>. [thesis], Atlanta, GA: Anatomy and Cell Biology, Emory University; 1998.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR52</td><td>BibBook</td><td>Ramamoorthy S.<Emphasis Type="Italic">Regulation of monoamine transporters: Regulated phosphorylation, dephosphorylation, and trafficking</Emphasis>. Totowa, NJ: Humana Press Inc; 2002.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1385/1-59259-158-2:001>10.1385/1-59259-158-2:001</a></td><td><b>CrossRef-Meta</b></td>
<td>BookTitle, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR53</td><td>BibArticle</td><td>Wakade AR, Wakade TD, Poosch M, Bannon MJ. Noradrenaline transport and transporter mRNA of rat chromaffin cells are controlled by dexamethasone and nerve growth factor.<Emphasis Type="Italic">J Physiol.</Emphasis> 1996;494:67&#8211;75.</td><td><a href=http://dx.doi.org/10.1113/jphysiol.1996.sp021476>10.1113/jphysiol.1996.sp021476</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, ArticleTitle, Author_FamilyName_1, Author_FamilyName_2, FirstPage, VolumeID</td><td>CrossRef</td></tr><tr><td>CR54</td><td>BibArticle</td><td>Figlewicz DP, Szot P, Israel PA, Payne C, Dorsa DM. Insulin reduces norepinephrine transporter mRNA in vivo in rat locus coeruleus.<Emphasis Type="Italic">Brain Res.</Emphasis> 1993;602:161&#8211;164.</td><td><a href=http://dx.doi.org/10.1016/0006-8993(93)90258-O>10.1016/0006-8993(93)90258-O</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR55</td><td>BibArticle</td><td>Meyer JS, Shearman LP, Collins LM. Monoamine transporters and the neurobehavioral teratology of cocaine.<Emphasis Type="Italic">Pharmacol Biochem Behav.</Emphasis> 1996;55:585&#8211;593.</td><td><a href=http://dx.doi.org/10.1016/S0091-3057(96)00280-8>10.1016/S0091-3057(96)00280-8</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR56</td><td>BibArticle</td><td>Ikeda T, Kitayama S, Morita K, Dohi T. Nerve growth factor down-regulates the expression of norepinephrine transporter in rat pheochromocytoma (PC12) cells.<Emphasis Type="Italic">Brain Res Mol Brain Res.</Emphasis> 2001;86:90&#8211;100.</td><td><a href=http://dx.doi.org/10.1016/S0169-328X(00)00272-2>10.1016/S0169-328X(00)00272-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR57</td><td>BibArticle</td><td>Fang Y, Ronnekleiv OK. Cocaine upregulates the dopamine transporter in fetal rhesus monkey brain.<Emphasis Type="Italic">J Neurosci.</Emphasis> 1999;19:8966&#8211;8978.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR58</td><td>BibArticle</td><td>Shearman LP, Meyer JS. Cocaine up-regulates norepinephrine transporter binding in the rat placenta.<Emphasis Type="Italic">Eur J Pharmacol.</Emphasis> 1999;386:1&#8211;6.</td><td><a href=http://dx.doi.org/10.1016/S0014-2999(99)00624-X>10.1016/S0014-2999(99)00624-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR59</td><td>BibArticle</td><td>Macey DJ, Smith HR, Nader MA, Porrino LJ. Chronic cocaine self-administration upregulates the norepinephrine transporter and alters functional activity in the bed nucleus of the stria terminalis of the rhesus monkey.<Emphasis Type="Italic">J Neurosci.</Emphasis> 2003;23:12&#8211;16.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR60</td><td>BibArticle</td><td>Li LB, Chen N, Ramamoorthy S, et al. The role of N-glycosylation in function and surface trafficking of the human dopamine transporter.<Emphasis Type="Italic">J Biol Chem.</Emphasis> 2004;279:21012&#8211;21020.</td><td><a href=http://dx.doi.org/10.1074/jbc.M311972200>10.1074/jbc.M311972200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR61</td><td>BibArticle</td><td>Vaughan RA, Huff RA, Uhl GR, Kuhar MJ. Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes.<Emphasis Type="Italic">J Biol Chem.</Emphasis> 1997;272:15541&#8211;15546.</td><td><a href=http://dx.doi.org/10.1074/jbc.272.24.15541>10.1074/jbc.272.24.15541</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR62</td><td>BibArticle</td><td>Ramamoorthy S, Giovanetti E, Qian Y, Blakely RD. Phosphorylation and regulation of antidepressant-sensitive serotonin transporters.<Emphasis Type="Italic">J Biol Chem.</Emphasis> 1998;273:2458&#8211;2466.</td><td><a href=http://dx.doi.org/10.1074/jbc.273.4.2458>10.1074/jbc.273.4.2458</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR63</td><td>BibArticle</td><td>Jayanthi LD, Samuvel DJ, Ramamoorthy S. Regulated internalization and phosphorylation of the native norepinephrine transporter in response to phorbol esters: evidence for localization in lipid rafts and lipid raft mediated internalization.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2004;279:19315&#8211;19326.</td><td><a href=http://dx.doi.org/10.1074/jbc.M311172200>10.1074/jbc.M311172200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR64</td><td>BibArticle</td><td>Apparsundaram S, Galli A, DeFelice LJ, Hartzell HC, Blakely RD. Acute regulation of norepinephrine transport. I. PKC-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1998;287:733&#8211;743.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR65</td><td>BibArticle</td><td>Apparsundaram S, Schroeter S, Blakely RD. Acute regulation of norepinephrine transport. II. PKC-modulated surface expression of human norepinephrine transporter proteins.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1998;287:744&#8211;751.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR66</td><td>BibArticle</td><td>Bauman AL, Apparsundaram S, Ramamoorthy S, Wadzinski BE, Vaughan RA, Blakely RD. Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A.<Emphasis Type="Italic">J Neurosci.</Emphasis> 2000;20:7571&#8211;7578.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR67</td><td>BibArticle</td><td>Qian Y, Galli A, Ramamoorthy S, Risso S, DeFelice LJ, Blakely RD. Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression.<Emphasis Type="Italic">J Neurosci.</Emphasis> 1997;17:45&#8211;57.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR68</td><td>BibArticle</td><td>Kitayama S, Dohi T, Uhl G. Phorbol esters alter functions of the expressed dopamine transporter.<Emphasis Type="Italic">Eur J Pharmacol.</Emphasis> 1994;268:115&#8211;119.</td><td><a href=http://dx.doi.org/10.1016/0922-4106(94)90180-5>10.1016/0922-4106(94)90180-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR69</td><td>BibArticle</td><td>Zhang L, Coffey LL, Reith MEA. Regulation of the functional activity of the human dopamine transporter by protein kinase C.<Emphasis Type="Italic">Biochem Pharmacol</Emphasis>. 1997;53:677&#8211;688.</td><td><a href=http://dx.doi.org/10.1016/S0006-2952(96)00898-2>10.1016/S0006-2952(96)00898-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR70</td><td>BibArticle</td><td>Daniels G, Amara SG. Regulation trafficking of the human dopamine transporter clathrin-mediated internalization and lysosomal degradation in response to phorbol esters.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 1999;274:35794&#8211;35801.</td><td><a href=http://dx.doi.org/10.1074/jbc.274.50.35794>10.1074/jbc.274.50.35794</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR71</td><td>BibArticle</td><td>Melikian HE, Buckley KM. Membrane trafficking regulates the activity of the human dopamine transporter.<Emphasis Type="Italic">J Neurosci</Emphasis>. 1999;19:7699&#8211;7710.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR72</td><td>BibArticle</td><td>Loder MK, Melikian HE. The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2003;278:22168&#8211;22174.</td><td><a href=http://dx.doi.org/10.1074/jbc.M301845200>10.1074/jbc.M301845200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR73</td><td>BibArticle</td><td>Sorkina T, Hoover BR, Zahniser NR, Sorkin A. Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism.<Emphasis Type="Italic">Traffic</Emphasis>. 2005;6:157&#8211;170.</td><td><a href=http://dx.doi.org/10.1111/j.1600-0854.2005.00259.x>10.1111/j.1600-0854.2005.00259.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR74</td><td>BibArticle</td><td>Holton KL, Loder MK, Melikian HE. Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization.<Emphasis Type="Italic">Nat Neurosci.</Emphasis> 2005;8:881&#8211;888.</td><td><a href=http://dx.doi.org/10.1038/nn1478>10.1038/nn1478</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, Year, Author_FamilyName_2, Author_FamilyName_1, VolumeID, FirstPage</td><td>CrossRef</td></tr><tr><td>CR75</td><td>BibArticle</td><td>Samuvel DJ, Jayanthi LD, Bhat NR, Ramamoorthy S. A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2005;25:29&#8211;41.</td><td><a href=http://dx.doi.org/10.1523/JNEUROSCI.3754-04.2005>10.1523/JNEUROSCI.3754-04.2005</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR76</td><td>BibArticle</td><td>Ramamoorthy S, Prasa PD, Kulanthaivel P, Leibach FH, Blakely RD, Ganapathy V. Expression of a cocaine-sensitive norepinephrine transporter in the human placental syncitiotrophoblast.<Emphasis Type="Italic">Biochemistry.</Emphasis> 1993;32:1346&#8211;1353.</td><td><a href=http://dx.doi.org/10.1021/bi00056a021>10.1021/bi00056a021</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR77</td><td>BibArticle</td><td>Ramamoorthy JD, Ramamoorthy S, Leibach FH, Ganapathy V. Human placental monoamine transporters as targets for amphetamines.<Emphasis Type="Italic">Am J Obstet Gynecol</Emphasis>. 1995;173:1782&#8211;1787.</td><td><a href=http://dx.doi.org/10.1016/0002-9378(95)90427-1>10.1016/0002-9378(95)90427-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR78</td><td>BibArticle</td><td>Jayanthi LD, Prasad PD, Ramamoorthy S, Mahesh VB, Leibach FH, Ganapathy V. Sodium- and chloride-dependent, cocaine-sensitive, high-affinity binding of nisoxetine to the human placental norepinephrine transporter.<Emphasis Type="Italic">Biochemistry</Emphasis>. 1993;32:12178&#8211;12185.</td><td><a href=http://dx.doi.org/10.1021/bi00096a030>10.1021/bi00096a030</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR79</td><td>BibArticle</td><td>Chamberlain LH, Gould GW. The vesicle- and target-SNARE proteins that mediate Glut4 vesicle fusion are localized in detergent-insoluble lipid rafts present on distinct intracellular membranes.<Emphasis Type="Italic">J Biol Chem.</Emphasis> 2002;277:49750&#8211;49754.</td><td><a href=http://dx.doi.org/10.1074/jbc.M206936200>10.1074/jbc.M206936200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR80</td><td>BibArticle</td><td>Simons K, Toomre D. Lipid rafts and signal transduction.<Emphasis Type="Italic">Nat Rev Mol Cell Biol.</Emphasis> 2000;1:31&#8211;39.</td><td><a href=http://dx.doi.org/10.1038/35036052>10.1038/35036052</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR81</td><td>BibArticle</td><td>Simons K, Ikonen E. Functional rafts in cell membranes.<Emphasis Type="Italic">Nature.</Emphasis> 1997;387:569&#8211;572.</td><td><a href=http://dx.doi.org/10.1038/42408>10.1038/42408</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR82</td><td>BibArticle</td><td>Parton RG, Richards AA. Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms.<Emphasis Type="Italic">Traffic.</Emphasis> 2003;4:724&#8211;738.</td><td><a href=http://dx.doi.org/10.1034/j.1600-0854.2003.00128.x>10.1034/j.1600-0854.2003.00128.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR83</td><td>BibArticle</td><td>Apparsundaram S, Sung U, Price RD, Blakely RD. Trafficking-dependent and- independent pathways of neurotransmitter transporter regulation differentially involving p38 mitogen-activated protein kinase revealed in studies of insulin modulation of norepinephrine transport in SK-N-SH cells.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2001;299:666&#8211;677.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR84</td><td>BibArticle</td><td>Carvelli L, Moron JA, Kahlig KM, et al. PI 3-kinase regulation of dopamine uptake.<Emphasis Type="Italic">J Neurochem</Emphasis>. 2002;81:859&#8211;869.</td><td><a href=http://dx.doi.org/10.1046/j.1471-4159.2002.00892.x>10.1046/j.1471-4159.2002.00892.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR85</td><td>BibArticle</td><td>Moron JA, Zakharova I, Ferrer JV, et al. Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2003;23:8480&#8211;8488.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR86</td><td>BibArticle</td><td>Zhu CB, Hewlett WA, Feoktistov I, Biaggioni I, Blakely RD. Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2004;65:1462&#8211;1474.</td><td><a href=http://dx.doi.org/10.1124/mol.65.6.1462>10.1124/mol.65.6.1462</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR87</td><td>BibArticle</td><td>Chaouloff F, Berton O, Mormede P. Serotonin and stress.<Emphasis Type="Italic">Neuropsychopharmacology</Emphasis>. 1999;21:28S-32S.</td><td><a href=http://dx.doi.org/10.1016/S0893-133X(99)00008-1>10.1016/S0893-133X(99)00008-1</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, VolumeID, JournalTitle, Year, ArticleTitle, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR88</td><td>BibArticle</td><td>Miller KJ, Hoffman BJ. Adenosine A<Subscript>3</Subscript> receptors regulate serotonin transport via nitric oxide and cGMP.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 1994;269:27351&#8211;27356.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR89</td><td>BibArticle</td><td>Huff RA, Vaughan RA, Kuhar MJ, Uhl GR. Phorbol esters increase dopamine transporter phosphorylation and decrease transport V<Subscript>max</Subscript>.<Emphasis Type="Italic">J Neurochem</Emphasis>. 1997;68:225&#8211;232.</td><td><a href=http://dx.doi.org/10.1046/j.1471-4159.1997.68010225.x>10.1046/j.1471-4159.1997.68010225.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR90</td><td>BibArticle</td><td>Ramamoorthy S, Blakely RD. Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants.<Emphasis Type="Italic">Science</Emphasis>. 1999;285:763&#8211;766.</td><td><a href=http://dx.doi.org/10.1126/science.285.5428.763>10.1126/science.285.5428.763</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR91</td><td>BibArticle</td><td>Foster JD, Pananusorn B, Vaughan RA. Dopamine transporters are phosphorylated on N-terminal serines in rat striatum.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2002;277:25178&#8211;25186.</td><td><a href=http://dx.doi.org/10.1074/jbc.M200294200>10.1074/jbc.M200294200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR92</td><td>BibArticle</td><td>Bonisch H, Hammermann R, Bruss M. Role of protein kinase C and second messengers in regulation of the norepinephrine transporter.<Emphasis Type="Italic">Adv Pharmacol</Emphasis>. 1998;42:183&#8211;186.</td><td><a href=http://dx.doi.org/10.1016/S1054-3589(08)60723-1>10.1016/S1054-3589(08)60723-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR93</td><td>BibArticle</td><td>Whitworth TL, Quick MW. Upregulation of gamma-aminobutyric acid transporter expression: role of alkylated gamma-aminobutyric acid derivatives.<Emphasis Type="Italic">Biochem Soc Trans</Emphasis>. 2001;29:736&#8211;741.</td><td><a href=http://dx.doi.org/10.1042/BST0290736>10.1042/BST0290736</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR94</td><td>BibArticle</td><td>Granas C, Ferrer J, Loland CJ, Javitch JA, Gether U. N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2003;278:4990&#8211;5000.</td><td><a href=http://dx.doi.org/10.1074/jbc.M205058200>10.1074/jbc.M205058200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR95</td><td>BibArticle</td><td>Lin Z, Zhang PW, Zhu X, et al. Phosphatidylinositol 3-kinase, protein kinase C, and MEK1/2 kinase regulation of dopamine transporters (DAT) require N-terminal DAT phosphoacceptor sites.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2003;278:20162&#8211;20170.</td><td><a href=http://dx.doi.org/10.1074/jbc.M209584200>10.1074/jbc.M209584200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR96</td><td>BibArticle</td><td>Doolen S, Zahniser NR. Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2001;296:931&#8211;938.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR97</td><td>BibArticle</td><td>Law RM, Stafford A, Quick MW. Functional regulation of gamma-aminobutyric acid transporters by direct tyrosine phosphorylation.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2000;275:23986&#8211;23991.</td><td><a href=http://dx.doi.org/10.1074/jbc.M910283199>10.1074/jbc.M910283199</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR98</td><td>BibArticle</td><td>Whitworth TL, Quick MW. Substrate-induced regulation of gamma-aminobutyric acid transporter trafficking requires tyrosine phosphorylation.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2001;276:42932&#8211;42937.</td><td><a href=http://dx.doi.org/10.1074/jbc.M107638200>10.1074/jbc.M107638200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR99</td><td>BibArticle</td><td>Quick MW, Hu J, Wang D, Zhang HY. Regulation of a gamma-aminobutyric acid transporter by reciprocal tyrosine and serine phosphorylation.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2004;279:15961&#8211;15967.</td><td><a href=http://dx.doi.org/10.1074/jbc.M306924200>10.1074/jbc.M306924200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR100</td><td>BibArticle</td><td>Sung U, Apparsundaram S, Galli A, et al. A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2003;23:1697&#8211;1709.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR101</td><td>BibArticle</td><td>Bauman PA, Blakely RD. Determinants within the C-terminus of the human norepinephrine transporter dictate transporter trafficking, stability, and activity.<Emphasis Type="Italic">Arch Biochem Biophys</Emphasis>. 2002;404:80&#8211;91.</td><td><a href=http://dx.doi.org/10.1016/S0003-9861(02)00232-1>10.1016/S0003-9861(02)00232-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR102</td><td>BibArticle</td><td>Uhl GR, Lin Z. The top 20 dopamine transporter mutants: structure-function relationships and cocaine actions.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2003;479:71&#8211;82.</td><td><a href=http://dx.doi.org/10.1016/j.ejphar.2003.08.058>10.1016/j.ejphar.2003.08.058</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR103</td><td>BibArticle</td><td>Goldberg NR, Beuming T, Soyer OS, Goldstein RA, Weinstein H, Javitch JA. Probing conformational changes in neurotransmitter transporters: a structural context.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2003;479:3&#8211;12.</td><td><a href=http://dx.doi.org/10.1016/j.ejphar.2003.08.052>10.1016/j.ejphar.2003.08.052</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR104</td><td>BibArticle</td><td>Loland CJ, Granas C, Javitch JA, Gether U. Identification of intracellular residues in the dopamine transporter critical for regulation of transporter conformation and cocaine binding.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2004;279:3228&#8211;3238.</td><td><a href=http://dx.doi.org/10.1074/jbc.M304755200>10.1074/jbc.M304755200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR105</td><td>BibArticle</td><td>Fornes A, Nunez E, Aragon C, Lopez-Corcuera B. The second intracellular loop of the glycine transporter 2 contains crucial residues for glycine transport and phorbol ester-induced regulation.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2004;279:22934&#8211;22943.</td><td><a href=http://dx.doi.org/10.1074/jbc.M401337200>10.1074/jbc.M401337200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR106</td><td>BibArticle</td><td>Deken SL, Beckman ML, Boos L, Quick MW. Transport rates of GABA transporters: regulation by the N-terminal domain and syntaxin 1A.<Emphasis Type="Italic">Nat Neurosci</Emphasis>. 2000;3:998&#8211;1003.</td><td><a href=http://dx.doi.org/10.1038/79939>10.1038/79939</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR107</td><td>BibArticle</td><td>Horton N, Quick MW. Syntaxin 1A up-regulates GABA transporter expression by subcellular redistribution.<Emphasis Type="Italic">Mol Membr Biol</Emphasis>. 2001;18:39&#8211;44.</td><td><a href=http://dx.doi.org/10.1080/09687680010029383>10.1080/09687680010029383</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR108</td><td>BibArticle</td><td>Wang D, Deken SL, Whitworth TL, Quick MW. Syntaxin 1A inhibits GABA flux, efflux, and exchange mediated by the rat brain GABA transporter GAT1.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2003;64:905&#8211;913.</td><td><a href=http://dx.doi.org/10.1124/mol.64.4.905>10.1124/mol.64.4.905</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR109</td><td>BibArticle</td><td>Haase J, Killian AM, Magnani F, Williams C. Regulation of the serotonin transporter by interacting proteins.<Emphasis Type="Italic">Biochem Soc Trans</Emphasis>. 2001;29:722&#8211;728.</td><td><a href=http://dx.doi.org/10.1042/BST0290722>10.1042/BST0290722</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR110</td><td>BibArticle</td><td>Torres GE, Yao WD, Mohn AR, et al. Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1.<Emphasis Type="Italic">Neuron</Emphasis>. 2001;30:121&#8211;134.</td><td><a href=http://dx.doi.org/10.1016/S0896-6273(01)00267-7>10.1016/S0896-6273(01)00267-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR111</td><td>BibArticle</td><td>Lee FJ, Liu F, Pristupa ZB, Niznik HB. Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis.<Emphasis Type="Italic">FASEB J</Emphasis>. 2001;15:916&#8211;926.</td><td><a href=http://dx.doi.org/10.1096/fj.00-0334com>10.1096/fj.00-0334com</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR112</td><td>BibArticle</td><td>Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the a-synuclein gene identified in families with Parkinson&#8217;s disease.<Emphasis Type="Italic">Science</Emphasis> 1997;276:2045&#8211;2047.</td><td><a href=http://dx.doi.org/10.1126/science.276.5321.2045>10.1126/science.276.5321.2045</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR113</td><td>BibArticle</td><td>Wersinger C, Vernier P, Sidhu A. Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant.<Emphasis Type="Italic">Biochemistry</Emphasis>. 2004;43:1242&#8211;1253.</td><td><a href=http://dx.doi.org/10.1021/bi035308s>10.1021/bi035308s</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR114</td><td>BibArticle</td><td>Carneiro AM, Ingram SL, Beaulieu JM, et al. The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2002;22:7045&#8211;7054.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR115</td><td>BibArticle</td><td>Saunders C, Ferrer JV, Shi L, et al. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2000;97:6850&#8211;6855.</td><td><a href=http://dx.doi.org/10.1073/pnas.110035297>10.1073/pnas.110035297</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR116</td><td>BibArticle</td><td>Daws LC, Callaghan PD, Moron JA, et al. Cocaine increases dopamine uptake and cell surface expression of dopamine transporters.<Emphasis Type="Italic">Biochem Biophys Res Commun</Emphasis>. 2002;290:1545&#8211;1550.</td><td><a href=http://dx.doi.org/10.1006/bbrc.2002.6384>10.1006/bbrc.2002.6384</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR117</td><td>BibArticle</td><td>Little KY, Elmer LW, Zhong H, Scheys JO, Zhang L. Cocaine induction of dopamine transporter trafficking to the plasma membrane.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2002;61:436&#8211;445.</td><td><a href=http://dx.doi.org/10.1124/mol.61.2.436>10.1124/mol.61.2.436</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR118</td><td>BibArticle</td><td>Bernstein EM, Quick MW. Regulation of gamma-aminobutyric acid (GABA) transporters by extracellular GABA.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 1999;274:889&#8211;895.</td><td><a href=http://dx.doi.org/10.1074/jbc.274.2.889>10.1074/jbc.274.2.889</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR119</td><td>BibArticle</td><td>Munir M, Correale DM, Robinson MB. Substrate-induced up-regulation of Na(+)-dependent glutamate transport activity.<Emphasis Type="Italic">Neurochem Int</Emphasis>. 2000;37:147&#8211;162.</td><td><a href=http://dx.doi.org/10.1016/S0197-0186(00)00018-8>10.1016/S0197-0186(00)00018-8</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR120</td><td>BibArticle</td><td>Quick MW. Substrates regulate gamma-aminobutyric acid transporters in a syntaxin 1A-dependent manner.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2002;99:5686&#8211;5691.</td><td><a href=http://dx.doi.org/10.1073/pnas.082712899>10.1073/pnas.082712899</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR121</td><td>BibArticle</td><td>Hahn MK, Mazei-Robison M, Blakely RD. Single nucleotide polymorphisms in the human norepinephrine transporter gene impact expression, trafficking, antidepressant interaction and protein kinase C regulation.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2005;68:457&#8211;466.</td><td><a href=http://dx.doi.org/10.1124/mol.105.011270>10.1124/mol.105.011270</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR122</td><td>BibArticle</td><td>Prasad HC, Zhu C, McCauley JL, et al. Human serotonin transporter variants display selective insensitivity to protein kinase G and p38 mitogen activated kinase.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2005;102:11545&#8211;11550.</td><td><a href=http://dx.doi.org/10.1073/pnas.0501432102>10.1073/pnas.0501432102</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>